IMTX Immatics N.V.
Healthcare$11.62+5.06%ClosedMarket Cap: $1.56B
As of 2026-05-25
Valuation
P/E (TTM)
—
PEG
—
P/B
2.95
P/S
35.90
EV/EBITDA
-4.96
DCF Value
$-2.09
FCF Yield
-14.1%
Div Yield
0.0%
Margins & Returns
Gross Margin
100.0%
Operating Margin
-570.3%
Net Margin
-577.4%
ROE
-45.5%
ROA
-39.6%
ROIC
-43.1%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $7.6M | 100.0% | $-66.1M | $-58.8M | $— | — |
| Q4 null | $19.8M | 100.0% | $-38.9M | $-35.7M | $— | — |
| FY null | $48.3M | 100.0% | $-182.0M | $-196.4M | $— | — |
| Q3 null | $5.2M | 100.0% | $-54.6M | $-50.5M | $— | — |
| Q2 null | $4.7M | 100.0% | $-53.1M | $-70.3M | $— | — |
| Q1 null | $18.6M | 100.0% | $-35.4M | $-39.9M | $— | — |
| Q4 null | $56.3M | 100.0% | $903.0K | $44.9M | $— | — |
| FY null | $155.8M | 100.0% | $-38.6M | $15.2M | $— | — |
| Q3 null | $50.6M | 100.0% | $514.0K | $-8.6M | $— | — |
| Q2 null | $18.8M | 99.5% | $-26.6M | $-18.0M | $— | — |
| Q1 null | $30.4M | -5.5% | $-13.6M | $-3.1M | $— | — |
| Q4 2023 | $15.9M | -109.0% | $-27.7M | $-26.1M | $-0.31 | — |